A.YU. TEREGULOV^1, 2, B.N. BODJGUA¹, M.B. YAKOVLEV¹, D.P. DOSMANOVA², B.M. GADIEV¹

 ¹Republic Clinical Hospital, Kazan

²Kazan (Volga Region) Federal University, Kazan

 Contact details:

Teregulov A.Yu. — PhD (medicine), Head of the Department of X-ray Surgical Methods of Diagnosis and Treatment, Associate Professor of the Department of Surgical Diseases of Postgraduate Education, Chief freelance specialist of the Republic of Tatarstan on X-ray endovascular diagnostics and treatment

Address: 138 Orenburgskiy trakt, Kazan, Russian Federation, 420064, tel.: +7-917-269-58-40, e-mail: tereg@yandex.ru

The purpose — to analyze current data on renal artery stenting in vasorenal hypertension, ischemic nephropathy, and end-stage renal failure; to consider a clinical case.

Material and methods. A clinical case is presented of bilateral stenting of the renal arteries in a patient with vasorenal hypertension, chronic kidney disease of the fifth degree in a multidisciplinary hospital with a favorable course. The article describes the clinical results after endovascular intervention, a literature review on the management and selection of patients with renal artery stenosis for revascularization.

Results. After simultaneous bilateral stenting of the renal arteries in a patient with end-stage renal insufficiency, renal function returned to normal; the patient stopped the sessions of programmed hemodialysis.

Conclusions. Stenting of renal arteries can normalize the kidney function even in the terminal stage of chronic kidney disease. There are no clear clinical recommendations for the selection of patients for renal arteries endovascular stenting in the terminal stage of chronic kidney disease. The tactic of simultaneous bilateral stenting was obviously justified in this clinical case.

Key words: renal arteries stenosis, renal arteries stenting, hemodialysis, vasorenal hypertension, ischemic nephropathy, chronic kidney disease. 

REFERENCES

1. Klinicheskie rekomendatsii. Rossiyskoe kardiologicheskoe obshchestvo. Arterial’naya gipertenziya u vzroslykh [Clinical recommendations. Russian Society of Cardiology. Arterial hypertension in adults], 2020. P. 136.
2. Spinowitz B.S., Rodriguez J.M. Renal Artery Stenosis. Medscape, 2022.
3. Klinicheskie rekomendatsii po diagnostike i lecheniyu renovaskulyarnoy gipertenzii i ishemicheskoy bolezni pochek. Assotsiatsiya nefrologov. Nauchnoe obshchestvo nefrologov Rossii, pod red. E.M. Shilova, M.M. Batyushina [Clinical guidelines for the diagnosis and treatment of renovascular hypertension and ischemic kidney disease. Association of Nephrologists. Scientific Society of Nephrologists of Russia, ed. E.M. Shilov, M.M. Batyushin], 2015. Pp. 6–7.
4. Parikh S.A., Shishehbor M.H., Gray B.H. SCAI expert consensus statement for renal artery stenting appropriate use. Catheterization and Cardiovascular Interventions, 2014, vol. 84, pp. 1163–1171.
5. Boutari Ch., Georgianou E., Sachinidis A. et al. Renovascular Hypertension: Novel Insights. Current Hypertension Reviews, 2020, vol. 16, pp. 24–29.
6. Samadian F., Dalili N., Jamalian A. New Insinghts into Pathophysiology, Diagnosis, and Treatment of Renovascular HypertensionIranian Journal of Kidney Diseases, 2017, vol. 11, pp. 79–89.
7. Çoner A., Çiçek D., Akıncı S., Müderrisoğlu H. Renal artery stenting of chronic kidney disease patient with resistant hypertension. The Anatolian Journal of Cardioligy, 2016, vol. 16 (11), p. 894.
8. Wiecek A., Chudek J., Adamczak M. Indications for renal revascularization—the landscape after the ASTRAL study. Nephrology Dialysis Transplantation, 2010, vol. 25, pp. 2399-2402.
9. Prince M., Tafur J.D., White Ch.J. When and how should we revascularize patients with atherosclerotic renal artery stenosis? JACC: Cardiovascular Interventions, 2019, vol. 12, pp. 505–517.
10. Cooper Ch.J., Murphy T.P., Cutlip D.E. et al. Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis. The New England Journal of Medicine, 2014, vol. 370, pp. 13–22.
11. Ritchie J., Green D., Chrysochou C. et al. High-Risk Clinical Presentations in Atherosclerotic Renovascular Disease: Prognosis and Response to Renal Artery Revascularization. The American Journal of Kidney Diseases, 2014, vol. 63, pp. 186–197.
12. Meredith D., Bazemore T.C., Shah A., Dilley J., Stouffer G.A. Identification of Factors Associated with Improved Survival After Renal Artery Stenting. The American Journal of Cardiology, 2017, vol. 119, pp. 664–668.
13. Iwashima Y., Ishimitsu T. How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment? Hypertension Research, 2020, vol. 43, pp. 1015–1027.
14. Karanikola E., Karaolanis G., Galyfos G. Et al. Endovascular Management of Atherosclerotic Renal Artery Stenosis: Post-Cardiovascular Outcomes in Renal Atherosclerotic Lesions Era Winner or False Alarm? Vascular Specialist International, 2017, vol. 33 (1), pp. 1–15.
15. Ueda T., Aoki H., Ushio Y. et al. Salvage from hemodialysis via percutaneous transluminal renal artery stenting for a jeopardized solitary functioning kidney: A case report. Journal of Cardiology Cases, 2021, vol. 24, pp. 268–271.